Here are four things to know.
1. MRA aims to help healthcare providers resolve complex motor vehicle and workers’ compensation accident claims, according to a news release. Additionally, the company provides underpayment identification and recovery services through its Ft. Lauderdale, Fla.-based payment integrity division.
2. Along with the transaction, Bobby Rolfe, MRA’s CEO for the past four years, and MRA President Lyle Beasley will remain involved with the company and continue their investment in MRA, the release states. Mr. Rolfe will serve as a consultant to MRA and Mr. Beasley will continue serving as a company board member.
3. Julie Klapstein, a member of Riverside Partners’ healthcare advisory board and founding CEO of healthcare technology services company Availity, will serve as CEO of MRA.
4. “I could not be more excited about the future of MRA as a result of this investment by Riverside Partners,” Mr. Rolfe said in the release. “Our team’s customer-first attitude is the cornerstone of our success, and Riverside Partners’ philosophy of empowering and supporting successful teams will enable each of our employees to continue their passion for serving our hospital customers.”
More articles on healthcare finance:
Moody’s downgrades MedStar Health’s rating to ‘Aa2’
S&P revises Massachusetts Ear and Eye’s outlook to negative
Louisiana Heart Hospital closes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
